We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVY icon
126
Avery Dennison
AVY
$13.4B
$6.03M 0.05%
52,879
+493
+0.9% +$54.2K
BCPC
127
Balchem Corp
BCPC
$5.72B
$5.94M 0.04%
62,570
-527
-0.8% -$49.3K
XLNX
128
DELISTED
Xilinx Inc
XLNX
$5.92M 0.04%
60,163
-8,400
-12% -$745K
AIT icon
129
Applied Industrial Technologies
AIT
$13.3B
$5.82M 0.04%
93,300
GOOG icon
130
Alphabet (Google) Class C
GOOG
$4.32T
$5.74M 0.04%
81,200
+320
+0.4% +$21.6K
FFBC icon
131
First Financial Bancorp
FFBC
$3.53B
$5.72M 0.04%
411,823
-368
-0.1% -$5.07K
FLO icon
132
Flowers Foods
FLO
$1.57B
$5.67M 0.04%
253,318
+240
+0.1% +$5.41K
NXST icon
133
Nexstar Media Group
NXST
$5.97B
$5.55M 0.04%
66,338
+8,642
+15% +$650K
ZTS icon
134
Zoetis
ZTS
$30B
$5.48M 0.04%
40,001
TTEK icon
135
Tetra Tech
TTEK
$9.07B
$5.32M 0.04%
336,425
+128,935
+62% +$1.96M
GLW icon
136
Corning
GLW
$143B
$5.24M 0.04%
202,284
+65,934
+48% +$1.49M
OTIS icon
137
Otis Worldwide
OTIS
$28.2B
$5.15M 0.04%
+90,609
New +$4.69M
CLX icon
138
Clorox
CLX
$12.7B
$4.88M 0.04%
22,251
BX icon
139
Blackstone
BX
$110B
$4.88M 0.04%
86,050
+1,125
+1% +$59.2K
TCF
140
DELISTED
TCF Financial Corporation Common Stock
TCF
$4.82M 0.04%
163,699
+1,323
+0.8% +$36.5K
DOW icon
141
Dow Inc
DOW
$21.2B
$4.75M 0.04%
116,509
+138
+0.1% +$5.05K
OGS icon
142
ONE Gas
OGS
$5.04B
$4.68M 0.04%
60,763
-860
-1% -$69.5K
WMT icon
143
Walmart Inc
WMT
$890B
$4.68M 0.04%
117,204
+264
+0.2% +$10.9K
CHE icon
144
Chemed
CHE
$7.22B
$4.66M 0.04%
10,324
-3,333
-24% -$1.49M
MMM icon
145
3M
MMM
$94.3B
$4.63M 0.03%
35,512
-3,015
-8% -$380K
LMAT icon
146
LeMaitre Vascular
LMAT
$1.86B
$4.57M 0.03%
173,222
-26,445
-13% -$691K
PEGA icon
147
Pegasystems
PEGA
$5.38B
$4.49M 0.03%
88,804
-20,392
-19% -$884K
SON icon
148
Sonoco
SON
$5.74B
$4.45M 0.03%
85,134
+13,778
+19% +$682K
WMB icon
149
Williams Companies
WMB
$86.1B
$4.43M 0.03%
233,104
-2,826
-1% -$52.6K
LMNX
150
DELISTED
Luminex Corp
LMNX
$4.43M 0.03%
136,172
-2,696
-2% -$85.3K

Similar funds

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.